Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection-Reference-Cited by-同舟云学术

Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 Infection

Published:2010-08-23 Issue:8 Volume:5 Page:e12357
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Kimpel Janine,Braun Stephen E.,Qiu Gang,Wong Fay Eng,Conolle Michelle,Schmitz Jörn E.,Brendel Christian,Humeau Laurent M.,Dropulic Boro,Rossi John J.,Berger Annemarie,von Laer Dorothee,Johnson R. Paul

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.;JA Sterne;Lancet,2005

2. Drug-resistant human immunodefiency virus.;MJ Kozal;Clin Microbiol Infect,2009

3. Future implications: compliance and failure with antiretroviral treatment.;AK Patel;J Postgrad Med,2006

4. Adverse effects of antiretroviral therapy for HIV infection.;V Montessori;CMAJ,2004

5. Setting the stage for bench-to-bedside movement of anti-HIV RNA inhibitors-gene therapy for AIDS in macaques.;SE Braun;Front Biosci,2006

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G;Molecular Therapy - Nucleic Acids;2023-09

2. Biallelic, Selectable, Knock-in Targeting of CCR5 via CRISPR-Cas9 Mediated Homology Directed Repair Inhibits HIV-1 Replication;Frontiers in Immunology;2022-03-21

3. Increased Efficiency for Biallelic Mutations of the CCR5 Gene by CRISPR-Cas9 Using Multiple Guide RNAs As a Novel Therapeutic Option for Human Immunodeficiency Virus;The CRISPR Journal;2021-02-01

4. CAR T cells: Living HIV drugs;Reviews in Medical Virology;2020-07-26

5. Humanized mice are precious tools for evaluation of hematopoietic gene therapies and preclinical modeling to move towards a clinical trial;Biochemical Pharmacology;2020-04